Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients

Cancer Genetics and Cytogenetics

Volumn 90, Issue 2, 1996, Pages 171-175

  Cuneo, Antonio ^a   Balsamo, Rosa ^a   Roberti, Maria Grazia ^a   Bardi, Antonella ^a   Piva, Nadia ^a   Balboni, Massimo ^a   Bigoni, Renato ^a   Rigolin, Gian Matteo ^a   Castoldi, Gianluigi ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CHROMOSOME 3P; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0030249681     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00129-X     Document Type: Article

References (23)

1. Morton CC(1995): Cytogenetics for the hematologist. In: Handin RI, Lux SE, Stossel TP (eds): Blood. Principles and practice of Hematology. J.B. Lippincott Company, Philadelphia, pp 93-124.
2. Sixth International Workshop on Chromosomes in Leukemia (1989): General Report. Cancer Genet Cytogenet 40:141-230.
3. Fifth International Workshop on chromosomes in Leukemia/ Lymphoma (1987): Correlation of chromosome abnormalities with histologic and immunologic characteristics in non Hodgkin's lymphoma and adult T-cell leukemia-lymphoma. Blood 70:1554-1564.
4. Van Den Berghe H (1991): Chromosomes in plasma-cell malignancies. Eur J Haematol 43(suppl 51):47-51.
5. Durie BGM (1992): Cellular and molecular genetic features of myeloma and related disorders. Hematol/Oncol Clin N Am 6:463-477.
6. Sawyer JR, Waldron JA, Jagannath S, Barlogie B (1995): Cytogenetic findings in 200 patients with Multiple Myeloma. Cancer Genet Cytogenet 82:41-49.
7. Weh HJ, Fiedler W, Hossfeld DK (1990): Cytogenetics in Multiple Myeloma: Are we studying the 'right' cells? Eur J Hematology 45:236.
8. Gutensohn K, Weh HJ, Walter TA, Hossfeld DK (1992): Cytogenetics in Multiple Myeloma and plasma cell leukemia: Simultaneous cytogenetic and cytologic studies in 51 patients. Ann Hematol 65:88-90.
9. Klein B, Bataille R (1992): Cytokine network in Human Multiple Myeloma. Hematol/Oncol Clin N Am 6:273-282.
10. Facon T, Lai JL, Nataf E, Preudhomme C, Zandecki M, Hammad M, Wattel E, Jouet JP, Bauters F (1993): Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: A report on 46 patients. Br J Haematol 84:743-745.
11. Smadja NV, Louvet C, Isnard F, Dutel JL, Grange MJ, Varette G, Krulik M (1995): Cytogenetic study in multiple myeloma at diagnosis: Comparison of two techniques. Br J Haematol 90:619-624.
12. Durie BGM, Salmon SE (1975): A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36:842-854.
13. Cuneo A, Tomasi P, Ferrari L, Piva N, Balboni M, Castoldi GL (1989): Cytogenetic analysis of different cellular populations in chronic myelomonocytic leukemia. Cancer Genet Cytogenet 37:29-37.
14. de la Maza M, Sanchez O (1976) Simultaneous G and C banding of human chromosomes. J Med Genet 13:235-243.
15. ISCN (1991): Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Mitelman F, ed. S. Karger, Basel, pp. 1-54.
16. Fagioli F, Lanza F, Carli MG, Cuneo A, Previati R, Carli MG, Castoldi GL (1991): Immunophenotypic, cytogenetic, and molecular investigations in two cases of CALLA-positive acute myeloid leukemia. Haematologica 75:407-411.
17. Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyc V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995): Improved Cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497.
18. Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu ZJ, Morel-Fournier B, Harousseau JL, Bataille R, Rossi JF, Klein B (1995): Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 85:2521-2527.
19. Dewald GW, Kyle RA, Hicks GA, Greipp PR (1985): The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66:380-390.
20. Weh HJ, Gutensohn K, Selbach J, Kruse R, Wacker-Backhaus G, Seeger D, Fielder W, Fett W, Hossfeld DK (1993): Karyotype in multiple myeloma and plasma cell leukaemia. Eur J Cancer 29:1269-1273.
21. Cigudosa JC, Calasanz MJ, Odero MD, Prosper F, Etxaniz A, Marin J, Rifon J, Gullon A, Rocha E (1994): Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other parameters. Cancer Genet Cytogenet 78:210-213.
22. Goulde J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B (1988): Plasma cell karyotype in multiple myeloma. Blood 71:453-455.
23. Sandberg AA (1990): The Chromosome in Human Cancer and Leukemia, 2nd Ed. Elsevier Science Publishing Co., New York, pp. 649-659.